Abbas Anwar, MD
Otolaryngology · Santa Monica, CANPI 1912267691
Payments from drug & device makers
Across 145 payments — averaging $30.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$841
- Regeneron Healthcare Solutions, Inc.$658
- Optinose US, Inc.$552
- Merz Pharmaceuticals, LLC$413
- Sanofi$396
- GSK$310
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,442100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 12 | $841 |
| Regeneron Healthcare Solutions, Inc. | 20 | $658 |
| Optinose US, Inc. | 35 | $552 |
| Merz Pharmaceuticals, LLC | 14 | $413 |
| Sanofi | 16 | $396 |
| GSK | 15 | $310 |
| Watermark Medical, Inc. | 1 | $232 |
| Aerin Medical Inc. | 3 | $185 |
| Integra Lifesciences Corporation | 3 | $182 |
| Smith+Nephew | 5 | $156 |
| Acclarent, Inc | 3 | $156 |
| Merz North America, Inc. | 2 | $60 |
| Medtronic | 2 | $53 |
| Hikma Pharmaceuticals USA | 3 | $48 |
| Intersect ENT, Inc. | 3 | $42 |
| Vertex | 1 | $29 |
| Acell, Inc. | 1 | $27 |
| Merck | 1 | $26 |
| Eyevance Pharmaceuticals LLC | 1 | $20 |
| Cook Medical LLC | 1 | $16 |
| Glenmark Therapeutics Inc. | 1 | $14 |
| KARL Storz Endoscopy-america | 1 | $13 |
| Checkpoint Surgical, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,442 in reported general payments places this provider in the 80th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 305 | $8,946 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 39 | $4,740 |
| Azelastine Hcl | 123 | $3,044 |
| Ofloxacin | 53 | $2,868 |
| Fluocinolone Acetonide Oil | 69 | $2,290 |
| Fluticasone Propionate | 163 | $1,888 |
| Levocetirizine Dihydrochloride | 14 | $624 |
| Methylprednisolone | 54 | $477 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 51 | $439 |
| Clarithromycin | 11 | $283 |
| Pantoprazole Sodium | 16 | $266 |
| Amitriptyline Hcl | 13 | $255 |
| Omeprazole | 26 | $245 |
| Montelukast Sodium | 25 | $226 |
| Cefdinir | 11 | $222 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Santa Monica
- Eric KezirianSanta Monica$98K
- Randall OwRoseville$4.3M
- Amir MoradiVista$2.6M
- Brian WeeksSan Diego$1.6M
- Charles LimbSan Francisco$1.5M
- Andrew BerosSan Diego$688K
- Paul SchalchChula Vista$573K
- Steven DavisTorrance$544K
- Arnaud BewleySacramento$541K
- Keith BlackwellLos Angeles$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.